Saltar al contenido
Merck
  • Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.

Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.

Journal of travel medicine (2012-04-26)
Sabine Stauga, Stefan Schmiedel
RESUMEN

Cerebral alveolar echinococcosis (AE) is a rare and difficult-to-treat zoonosis caused by Echinococcus multilocularis. A 29-year-old immigrant from Siberia with a past history of hepatic AE, presented with acute onset of grand mal seizures, weakness of the left leg, and cephalgia. Magnetic resonance imaging of the brain revealed inoperable right-sided infiltrative lesions, suggesting cerebral AE. Despite anthelmintic treatment only slow improvement occurred.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Albendazole sulfoxide, VETRANAL®, analytical standard
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad